Anika Therapeutics(CH:AKP)
CH:AKP
Anika Therapeutics Revenue
Anika Therapeutics (AKP) Revenue
0 Followers
Anika Therapeutics Revenue
Anika Therapeutics had a revenue of 30.59M in the quarter ending Sep 30, 2026, with -6.18%. This bring the company's revenue in the last twelve months to 123.43M, Increased 2.30%. In the fiscal year ending Dec 31, 2025, Anika Therapeutics had annual revenue of 112.82M with -5.91% growth.
- Revenue (ttm)
- 123.43M
- Revenue Growth
- 2.43%
- P/S Ratio
- 1.33
- Revenue/Employee
- CHF 480,081
- Employees
- 235
- Market Cap
- CHF 150.17M
Revenue Chart
Anika Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 112.82M | -7.09M | -5.91% |
| Dec 31, 2024 | 119.91M | -885.00K | -0.73% |
| Dec 31, 2023 | 120.79M | 6.96M | 6.12% |
| Dec 31, 2022 | 113.83M | -33.97M | -22.98% |
| Dec 31, 2021 | 147.79M | 17.34M | 13.29% |
| Dec 31, 2020 | 130.46M | 15.85M | 13.83% |
| Dec 31, 2019 | 114.61M | 9.05M | 8.58% |
| Dec 31, 2018 | 105.56M | -7.87M | -6.93% |
| Dec 31, 2017 | 113.42M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.